Responsible for managing Melanoma Portfolio in the US; Leading strategy & execution across all marketing verticals, enabling cross-functional and alliance collaboration; Driving performance to achieve market leadership in Melanoma

Responsible for driving strategic and executional excellence for BRAFTOVI + MEKTOVI launch in Lung Cancer; Spearheaded account activation efforts to drive performance for Melanoma & CRC at key Academic and Community accounts

Responsible for leading global pricing, access, and reimbursement strategies for peri-LOE and launch assets across RCC franchise; Served as Pfizer Oncology Value-Based Agreements Steering Committee Lead

Responsible for leading global pricing, access, and reimbursement strategies for Lung Cancer launch assets

Led Market Access business development engagements with Commercial Development and Business Development as main Oncology Pricing contact to inform Pfizer Oncology internal and external investment decisions

• Managed global projects across multiple therapy areas, including Breast, Lung, Hematological Cancers, Diabetes, and Pulmonary diseases• Projects ranged from pricing and market access, including development of payer value stories, pricing and contracting strategies, and loss-of-exclusivity/lifecycle plans to due diligence, and commercial strategy• Organized launch readiness negotiation workshops for Europe, APAC, Africa/Middle-East, and Latin America markets, training cross-functional Access, HEOR, Commercial, and Medical colleagues

• Worked on the development of a new product line that provides clients with insight into the inter-relationship of various plan benefit designs and the effect of out-of-pocket burden on patients• Proactively participated in strategic development and planning for new product initiatives from conception to early market evaluation, collaborating with other departments as well as external data sources• Served as lead for multiple key strategic clients, providing data support, analyses, and reporting on various therapeutic areas’ market landscape• Created standard biweekly reports monitoring payer reactions to several newly launched products while coordinating with clients to ensure accuracy and on-time delivery of all components• Developed expertise in payer management of several disease states, including research on drug coverage, interpretation of payer requirements, and quality control of information to drive client reports• Designed strategic reports using PowerPoint to present drug coverage information, specializing in Oncology, Ocular conditions, and Pulmonary Arterial Hypertension, while considering audiences requiring both a summarized and detailed understanding of the data• Served in a project management capacity on several projects, including documentation of project specifications, making decisions about timelines and priorities as well as addressing issues as they arose• Absorbed knowledge from others in organization to quickly expand overall contribution within the Prior Authorization Tracking Tool, as well as across other services

• Tested, identified, and analyzed multiple MIF and HMGb1 inhibitor molecules using various techniques and instruments including, but not limited to, protein expression and purification, SDS-PAGE, HPLC, Biacore T200, Biacore 3000, GC, various chromatographic methods, etc. • Analyzed and reported on data from neuroinflammatory agents’ clinical trials

• Detected trace quantities of gaseous Nitric Oxide using Cavity Ring Down Spectroscopy• Constructed a device that detects gaseous Nitric Oxide in human breath